Where
You Can Find Additional Information
Ramius
Capital and certain of its affiliates have filed a definitive proxy statement
with the SEC to solicit written consents
from shareholders of Orthofix to
call a special general meeting of shareholders for the purpose of making changes
to the
composition of Orthofix’s board of directors. Orthofix has
filed with the SEC a definitive proxy statement in connection
with its intent
to solicit written consent revocations from shareholders in opposition to
Ramius’ solicitation. If Orthofix
holds a special general meeting
at Ramius’ and other shareholders’ request, Orthofix intends to file with the
SEC, and
distribute to shareholders, a proxy statement opposing proposals
made by Ramius. SHAREHOLDERS ARE URGED
TO READ ORTHOFIX’S
DEFINITIVE PROXY MATERIALS AND ANY OTHER RELEVANT SOLICITATION
MATERIALS
FILED WITH THE SEC BECAUSE THEY CONTAIN IMPORTANT
INFORMATION. Investors and
shareholders may obtain a free copy of
proxy statements filed with the SEC by Orthofix at the SEC’s website
at
www.sec.gov or by contacting Georgeson, 199 Water Street, 26th Floor, New
York, NY 10038 or by calling (212) 440-
9800 (bankers and brokers) or
toll-free (800) 323-4133 (all others).
Orthofix
International N.V. and its directors and certain executive
officers are participants in the solicitation of written
consent
revocations from shareholders of Orthofix, as well as the solicitation of
proxies in connection with a special
general meeting of shareholders, if such
a meeting is called. The names of such persons are: James F. Gero,
Peter J.
Hewett, Jerry C. Benjamin, Charles W. Federico, Dr. Guy J. Jordan,
Ph.D., Thomas J. Kester, CPA, Alan W. Milinazzo,
Maria Sainz, Dr. Walter P.
von Wartburg, Kenneth R. Weisshaar, Robert S. Vaters, Michael Simpson, Bradley
R. Mason,
Raymond C. Kolls, J.D. and Michael M. Finegan. Information
regarding such participants, as well as each such person’s
respective
interests in Orthofix by security holdings or otherwise, is set forth in
Orthofix’s definitive proxy statement
relating to its intent to solicit
written consent revocations from shareholders in opposition to Ramius’
solicitation, which
may be obtained free of charge at the SEC’s website at
www.sec.gov and Orthofix’s
website at www.orthofix.com.
Notification
of Proxy Statement Filing